Stock Market News
SkinBioTherapeutics rockets as 'major milestone' reached by new cream
Shares in skin health specialist SkinBioTherapeutics stormed up 10% on Tuesday after a cream formulation of the company's SkinBiotix technology passed effectiveness in skin models.
SkinBiotix's technology utilises extracts of probiotic bacteria to improve the barrier function of skin through the increase of skin proteins, keeping moisture in and protecting from infection, with data showing a correlation between the amount of SkinBiotix in the cream and the prevalence of the protein.
The AIM-traded life sciences company, whose focus was on skin health, specifically on the cosmetics, infection control and eczema sectors. said the stability of the cream will undergo further testing in the coming weeks.
Catherine O'Neill, chief executive of SkinBioTherapeutics, said: "The incorporation of our SkinBiotix technology into an effective cream formulation is a major milestone in the development of products for the cosmetic market and, subject to stability testing, allows us to create formulations for our human study later this year."
Development of lotion and gel-based formulas containing SkinBiotix's technology was also underway.
As of 0827 BST, SkinBio Therapeutics' shares were up 10.05% at 10.73p.
SkinBiotix's technology utilises extracts of probiotic bacteria to improve the barrier function of skin through the increase of skin proteins, keeping moisture in and protecting from infection, with data showing a correlation between the amount of SkinBiotix in the cream and the prevalence of the protein.
The AIM-traded life sciences company, whose focus was on skin health, specifically on the cosmetics, infection control and eczema sectors. said the stability of the cream will undergo further testing in the coming weeks.
Catherine O'Neill, chief executive of SkinBioTherapeutics, said: "The incorporation of our SkinBiotix technology into an effective cream formulation is a major milestone in the development of products for the cosmetic market and, subject to stability testing, allows us to create formulations for our human study later this year."
Development of lotion and gel-based formulas containing SkinBiotix's technology was also underway.
As of 0827 BST, SkinBio Therapeutics' shares were up 10.05% at 10.73p.
Related share prices |
---|
SkinBioTherapeutics (SBTX) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price